JT-1 / Jantar GmbH - LARVOL DELTA

Proof-of-Concept Interventional Study With a Nasal Spray of JT-1 in Patients With Chronic Rhinitis or Chronic Sinusitis (clinicaltrials.gov) - P=N/A | N=3 | Terminated | Sponsor: Jantar GmbH | N=25 ➔ 3 | Trial completion date: Sep 2023 ➔ Mar 2023 | Recruiting ➔ Terminated | Trial primary completion date: Aug 2023 ➔ Mar 2023; regulatory issues

Enrollment change • Trial completion date • Trial primary completion date • Trial termination • Inflammation • Otorhinolaryngology • Respiratory Diseases • Sinusitis

Proof-of-Concept Interventional Study With a Nasal Spray of JT-1 in Patients With Chronic Rhinitis or Chronic Sinusitis (clinicaltrials.gov) - P=N/A | N=25 | Recruiting | Sponsor: Jantar GmbH | Not yet recruiting ➔ Recruiting

Enrollment open • Inflammation • Otorhinolaryngology • Respiratory Diseases • Sinusitis

Proof-of-Concept Interventional Study With a Nasal Spray of JT-1 in Patients With Chronic Rhinitis or Chronic Sinusitis (clinicaltrials.gov) - P=N/A | N=25 | Not yet recruiting | Sponsor: Jantar GmbH | Trial completion date: May 2023 ➔ Sep 2023 | Trial primary completion date: May 2023 ➔ Aug 2023

Trial completion date • Trial primary completion date • Inflammation • Otorhinolaryngology • Respiratory Diseases • Sinusitis

Proof-of-Concept Interventional Study With a Nasal Spray of JT-1 in Patients With Chronic Rhinitis or Chronic Sinusitis (clinicaltrials.gov) - P=N/A | N=25 | Not yet recruiting | Sponsor: Jantar GmbH

New trial • Inflammation • Otorhinolaryngology • Respiratory Diseases • Sinusitis